TW223073B - - Google Patents

Info

Publication number
TW223073B
TW223073B TW081107521A TW81107521A TW223073B TW 223073 B TW223073 B TW 223073B TW 081107521 A TW081107521 A TW 081107521A TW 81107521 A TW81107521 A TW 81107521A TW 223073 B TW223073 B TW 223073B
Authority
TW
Taiwan
Application number
TW081107521A
Other languages
Chinese (zh)
Original Assignee
Chem Pharm Forsch Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chem Pharm Forsch Gmbh filed Critical Chem Pharm Forsch Gmbh
Application granted granted Critical
Publication of TW223073B publication Critical patent/TW223073B/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW081107521A 1991-10-04 1992-09-23 TW223073B (US06826419-20041130-M00005.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0198791A AT398202B (de) 1991-10-04 1991-10-04 Neue imidazolderivate, verfahren zu ihrer herstellung und ihre verwendung

Publications (1)

Publication Number Publication Date
TW223073B true TW223073B (US06826419-20041130-M00005.png) 1994-05-01

Family

ID=3525398

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081107521A TW223073B (US06826419-20041130-M00005.png) 1991-10-04 1992-09-23

Country Status (22)

Country Link
US (1) US5298519A (US06826419-20041130-M00005.png)
EP (1) EP0535420A1 (US06826419-20041130-M00005.png)
JP (1) JP2544565B2 (US06826419-20041130-M00005.png)
CN (1) CN1032856C (US06826419-20041130-M00005.png)
AT (1) AT398202B (US06826419-20041130-M00005.png)
AU (1) AU649357B2 (US06826419-20041130-M00005.png)
CA (1) CA2079735A1 (US06826419-20041130-M00005.png)
CZ (1) CZ301992A3 (US06826419-20041130-M00005.png)
FI (1) FI924353A (US06826419-20041130-M00005.png)
HR (1) HRP920817A2 (US06826419-20041130-M00005.png)
HU (1) HUT62291A (US06826419-20041130-M00005.png)
IL (1) IL103329A (US06826419-20041130-M00005.png)
LV (1) LV10256B (US06826419-20041130-M00005.png)
MY (1) MY108350A (US06826419-20041130-M00005.png)
NO (1) NO923798L (US06826419-20041130-M00005.png)
NZ (1) NZ244320A (US06826419-20041130-M00005.png)
RU (1) RU2105764C1 (US06826419-20041130-M00005.png)
SI (1) SI9200240A (US06826419-20041130-M00005.png)
SK (1) SK301992A3 (US06826419-20041130-M00005.png)
TW (1) TW223073B (US06826419-20041130-M00005.png)
YU (1) YU48290B (US06826419-20041130-M00005.png)
ZA (1) ZA927205B (US06826419-20041130-M00005.png)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2105939B1 (es) * 1994-08-02 1998-07-01 Uriach & Cia Sa J Nuevos pirazoles con actividad antagonista de la angiotensina ii.
CN101024643A (zh) 2006-02-20 2007-08-29 上海艾力斯医药科技有限公司 咪唑-5-羧酸类衍生物、制备方法及其应用
CN101195615B (zh) * 2006-12-06 2013-03-27 深圳市信立泰资产管理有限公司 咪唑-5-羧酸衍生物的盐、制备方法及其药物组合物
AU2006351517B8 (en) * 2006-12-06 2012-01-19 Shenzhen Salubris Pharmaceuticals Co., Ltd. The salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof
CN101214242A (zh) * 2007-01-05 2008-07-09 上海艾力斯医药科技有限公司 新的药用组合物
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
CN101317842A (zh) * 2007-06-07 2008-12-10 上海艾力斯医药科技有限公司 一种咪唑-5-羧酸衍生物的治疗用途
CN101367795B (zh) * 2007-08-17 2012-05-02 上海艾力斯生物医药有限公司 一种咪唑-5-羧酸衍生物及其制备方法
CN101407511B (zh) * 2007-10-11 2013-01-09 上海艾力斯生物医药有限公司 一种结晶型的咪唑-5-羧酸衍生物
EP2328910B1 (en) 2008-06-04 2014-08-06 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
AU2009270833B2 (en) 2008-07-16 2015-02-19 Bausch Health Ireland Limited Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
CN103012377A (zh) * 2011-09-27 2013-04-03 江苏艾力斯生物医药有限公司 一种咪唑-5-羧酸酯的重结晶方法
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP2016514670A (ja) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド 他の薬物と組み合わせたグアニル酸シクラーゼ受容体アゴニスト
BR112015030326A2 (pt) 2013-06-05 2017-08-29 Synergy Pharmaceuticals Inc Agonistas ultrapuros de guanilato ciclase c, método de fabricar e usar os mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5064825A (en) * 1989-06-01 1991-11-12 Merck & Co., Inc. Angiotensin ii antagonists
AU645022B2 (en) * 1989-06-30 1994-01-06 E.I. Du Pont De Nemours And Company Fused-ring aryl substituted imidazoles
ATE113281T1 (de) * 1989-08-02 1994-11-15 Takeda Chemical Industries Ltd Pyrazol-derivate, verfahren zu deren herstellung und anwendung.
DE4132631A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Imidazolyl-propensaeurederivate
DE4132632A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Substituierte imidazolyl-propensaeurederivate
DE69329982T2 (de) * 1992-06-02 2001-09-27 Sankyo Co 4-Carboxyimidazolderivate als Angiotensin-II-Antagonisten und ihre therapeutische Verwendung

Also Published As

Publication number Publication date
NO923798L (no) 1993-04-05
EP0535420A1 (de) 1993-04-07
ATA198791A (de) 1994-02-15
RU2105764C1 (ru) 1998-02-27
JPH05310731A (ja) 1993-11-22
JP2544565B2 (ja) 1996-10-16
NZ244320A (en) 1995-01-27
SI9200240A (en) 1993-06-30
US5298519A (en) 1994-03-29
MY108350A (en) 1996-09-30
CZ301992A3 (en) 1993-08-11
HRP920817A2 (en) 1996-08-31
IL103329A0 (en) 1993-03-15
CA2079735A1 (en) 1993-04-05
LV10256B (en) 1995-04-20
CN1032856C (zh) 1996-09-25
IL103329A (en) 1996-10-31
SK301992A3 (en) 1995-10-11
HU9203149D0 (en) 1992-12-28
CN1071426A (zh) 1993-04-28
NO923798D0 (no) 1992-09-30
AT398202B (de) 1994-10-25
YU48290B (sh) 1998-05-15
LV10256A (lv) 1994-10-20
HUT62291A (en) 1993-04-28
FI924353A (fi) 1993-04-05
YU87592A (sh) 1995-10-03
ZA927205B (en) 1993-03-23
AU2617692A (en) 1993-04-08
AU649357B2 (en) 1994-05-19
FI924353A0 (fi) 1992-09-29

Similar Documents

Publication Publication Date Title
FR2680256B1 (US06826419-20041130-M00005.png)
DK0578681T3 (US06826419-20041130-M00005.png)
FR2681113B1 (US06826419-20041130-M00005.png)
DE4291263T1 (US06826419-20041130-M00005.png)
DE4291719T1 (US06826419-20041130-M00005.png)
DE4292255T1 (US06826419-20041130-M00005.png)
FR2682061B1 (US06826419-20041130-M00005.png)
TW223073B (US06826419-20041130-M00005.png)
FR2682130B1 (US06826419-20041130-M00005.png)
FR2671549B1 (US06826419-20041130-M00005.png)
EP0543016A4 (US06826419-20041130-M00005.png)
FR2685737B1 (US06826419-20041130-M00005.png)
FR2676513B1 (US06826419-20041130-M00005.png)
FR2674583B1 (US06826419-20041130-M00005.png)
FR2680027B1 (US06826419-20041130-M00005.png)
FR2685501B1 (US06826419-20041130-M00005.png)
FR2671715B1 (US06826419-20041130-M00005.png)
FR2685516B1 (US06826419-20041130-M00005.png)
FR2685147B1 (US06826419-20041130-M00005.png)
FR2685465B1 (US06826419-20041130-M00005.png)
IN172890B (US06826419-20041130-M00005.png)
EP0503968A3 (US06826419-20041130-M00005.png)
EP0538027A3 (US06826419-20041130-M00005.png)
PL291085A1 (US06826419-20041130-M00005.png)
EP0508666A3 (US06826419-20041130-M00005.png)